Private and public venture investing

We are a life science venture capital investor, delivering knowledge, network, and capital to companies.

Our approach to venture investments

We strive to invest in companies that develop innovative drugs, medical devices and diagnostics.

We focus on generating strong financial returns from our portfolio of venture companies. We invest in both private and public companies from an open evergreen fund. This funding structure enables us to take a long-term perspective.

With colleagues on the ground in Copenhagen, London, Singapore, San Francisco and Boston, we are well positioned in the major global life science hubs and can quickly respond to new and exciting investment opportunities wherever they emerge.

We primarily invest in biotechnology and medical technology. Within biotech we primarily invest in companies with clinical stage compounds. In medtech, we invest in commercial stage companies.

We work actively with the companies we invest in by serving on the Boards of Directors. Companies can also draw on our extensive network, as well as our commercial and scientific expertise within the life sciences.

During 2021, Novo Ventures executed 46 investments. We deployed DKK 3.2 billion during the year. Investment highlights include:

• Verve Therapeutics, a gene editing company hoping to lower LDL cholesterol for familial hypercholesterolemia and one of the first in vivo gene editing therapies to begin clinical trials
• Hummingbird Biosciences, a company using a systems biology approach to antibody discovery and development, and our first venture portfolio company with headquarters in Asia
• Numab Therapeutics, a next generation antibody fragment platform company whose lead programme has the potential to become new standard of care in immune checkpoint therapy
• Noom, a leading, high growth, global digital health platform

All teams

Key figures

Over the past 10 years

  • 1.75 bn

    invested.

  • 46

    investments executed during 2021.

  • 62

    portfolio companies in 2021.

Meet our team

We are a focused team with streamlined decision making and we are quick to respond to investment opportunities when they arise.

With professionals based out of Copenhagen, San Francisco, Boston and London and an international network of commercial and scientific specialists, our team is geared to invest in the major life science hubs.

Our locations

Novo Holdings A/S
Tuborg Havnevej 19
2900 Hellerup
Denmark
+45 3527 6500
ventures@novo.dk

Novo Ventures (US) Inc.*
501 2nd Street, Suite 300
San Francisco, CA 94107
USA
+1 (415) 552-6686

Novo Ventures (US) Inc.*
200 Clarendon Street, Floor 45
Boston, MA 02116
USA

Novo Ventures (UK)
12 Hay Hill
Mayfair, London W1J 8NR
UK

*Novo Ventures (US) Inc. is a separate legal entity that provides certain consultancy services to Novo Holdings A/S, mainly within the areas of identifying, analysing and negotiating various investment opportunities among life science and biotech companies in the US as well as certain follow-up activities related thereto, such as board memberships, financial control and reporting efforts.